2-Methyl-5-(piperidin-4-yl)-1,3,4-oxadiazole, 95.0%, 250mg

O-(2-(tert-butoxy)ethyl)hydroxylamine, 98%, 25g

(6-Fluoro-imidazo[1,2-a]pyridin-2-yl)-methanol, 95.0%, 1g

N-Phenylacrylamide, 95.0%, 100g

N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-3-(2-furyl)-L-alanine>98.0%(T)1g

3-(N-Morpholino)-2-hydroxypropanesulfonic acid,sodium salt (MOPSO-Na), 99.0%, 100g

2-Isobutoxy-4-(trifluoromethyl)phenylboronic acid, 97%, 5g

1,4,7-Trimethyl-1,4,7-triazacyclononane (stabilized with NaHCO3)>98.0%(GC)(T)5g

1-[[2'-(2,5-Dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]methyl]-2-ethoxy-1H-benzimidazole-7-carboxylic acid methyl ester, 98%, 5g

(2-Fluoro-6-methylphenyl)methanol, 95.0%, 5g

3-Bromo-2,5-difluoropyridine, 95.0%, 100mg

4-Bromo-7-(trifluoromethyl)-1H-indazole, 95.0%, 100mg

1,2-Di(1-naphthyl)ethane, 94.0%, 1g